Flagship Pioneering’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-27,562	Closed	-$11.8M	–	7
2017 Q1	$11.8M	Hold	27,562	–	–	3.15%	5
2016 Q4	$14.2M	Sell	27,562 -27,500	-50%	-$14.1M	4.61%	5
2016 Q3	$23.5M	Buy	+55,062	New	+$23.5M	6.43%	5